IN2012DN02879A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02879A
IN2012DN02879A IN2879DEN2012A IN2012DN02879A IN 2012DN02879 A IN2012DN02879 A IN 2012DN02879A IN 2879DEN2012 A IN2879DEN2012 A IN 2879DEN2012A IN 2012DN02879 A IN2012DN02879 A IN 2012DN02879A
Authority
IN
India
Prior art keywords
compositions
disclosed
nrtis
nnrtis
carrageenans
Prior art date
Application number
Inventor
Robin A Maguire
Mitchell Thorn
David M Phillips
Naomi Rutenberg
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of IN2012DN02879A publication Critical patent/IN2012DN02879A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more polyanionic microbicides, such as carrageenans, including lambda carrageenan, as well as water-soluble metal salts and specified antiretroviral agents comprising NNRTIs and NRTIs. Also disclosed are methods for making and using the compositions.
IN2879DEN2012 2009-10-06 2010-10-04 IN2012DN02879A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/587,405 US8367098B2 (en) 2002-04-30 2009-10-06 Unique combinations of antimicrobial compositions
PCT/US2010/051303 WO2011044034A1 (en) 2009-10-06 2010-10-04 Carrageenan-containing aqueous antimicrobial compositions

Publications (1)

Publication Number Publication Date
IN2012DN02879A true IN2012DN02879A (en) 2015-07-24

Family

ID=43036273

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2879DEN2012 IN2012DN02879A (en) 2009-10-06 2010-10-04

Country Status (15)

Country Link
US (1) US8367098B2 (en)
EP (1) EP2485710B1 (en)
JP (1) JP5911425B2 (en)
CN (1) CN102665677B (en)
AU (1) AU2010303721B2 (en)
BR (1) BR112012008040B1 (en)
CA (1) CA2775603C (en)
CO (1) CO6531457A2 (en)
ES (1) ES2550815T3 (en)
IN (1) IN2012DN02879A (en)
MX (1) MX337376B (en)
RU (1) RU2540423C2 (en)
UA (1) UA109117C2 (en)
WO (1) WO2011044034A1 (en)
ZA (1) ZA201202526B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541556B1 (en) 2012-03-02 2013-09-24 Empire Technology Development Llc Lignin derivatives and uses thereof
WO2014003753A1 (en) 2012-06-28 2014-01-03 Empire Technology Development Llc Lignin derivatives having polycations and uses thereof
EP2953629A1 (en) * 2013-02-05 2015-12-16 The Population Council, Inc. Intravaginal ring for the delivery of unique combinations of antimicrobial compositions
CA2899424A1 (en) 2013-02-19 2014-08-28 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for improving appearance and formation of scar tissue
EP3099311A1 (en) * 2014-01-28 2016-12-07 The Population Council, Inc. Combination product for the prevention of sexually transmitted infections
WO2016056001A1 (en) 2014-10-06 2016-04-14 Algamed Therapeutics (A.M.T) Ltd Compositions comprising sulfated polysaccharides and uses thereof
US9470676B2 (en) 2014-12-19 2016-10-18 Good Clean Love, Inc. Systems and methods for bio-matching gels, creams and lotions
US10195169B2 (en) 2014-12-19 2019-02-05 Good Clean Love, Inc. Systems and methods for bio-matching gels, creams and lotions
US10952979B2 (en) 2014-12-19 2021-03-23 Good Clean Love, Inc. Topical fertility promoting product and manufacturing method
US10485823B2 (en) * 2016-04-18 2019-11-26 Bioleaders Corporation Method for treating cervical intraepithelial neoplasia using poly-gamma- glutamic acid
US12043598B2 (en) 2018-03-20 2024-07-23 Lanvira, Llc Condoms lubricated with antiviral lubricious compositions containing lambda-carrageenan
US10688043B1 (en) 2018-03-20 2020-06-23 Mario Elmen Tremblay Personal lubricants comprising lambda-carrageenan
US12036313B2 (en) 2018-03-20 2024-07-16 Lanvira, Llc Personal lubricants comprising lambda-carrageenan
EP3810086B1 (en) 2018-05-10 2024-01-17 Mario Elmen Tremblay Lubricated substrates comprising lambda-carrageenan
KR101995376B1 (en) * 2018-08-20 2019-07-02 한미약품 주식회사 Antiviral Composition Comprising a Carrageenan as an Active Ingredient
CN119365077A (en) * 2022-06-14 2025-01-24 株式会社益力多本社 Antibacterial and antiviral agents and their uses

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626054A (en) * 1967-10-25 1971-12-07 Bard Hamilton Co Inc Lupus erythematosus skin test
JPS522983B2 (en) * 1973-06-05 1977-01-25
US4356264A (en) * 1980-04-11 1982-10-26 International Minerals & Chemical Corp. Zinc-containing antibiotic agents
US4532128A (en) * 1981-09-15 1985-07-30 Dynapol Quaternary ammonium group-containing polymers having antimicrobial activity
DK171716B1 (en) 1982-03-12 1997-04-07 Pharmacia & Upjohn Ab Process for the preparation of a complex of carrageenan and emepronium, doxycycline or propranolol
US5009867A (en) * 1984-10-09 1991-04-23 Kraft General Foods, Inc. C-gel composite pizza snack kit
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
EP0293826A3 (en) 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
US5272261A (en) * 1989-01-11 1993-12-21 Merrell Dow Pharmaceuticals Inc. Preparation of sulfated polysaccharide fractions
US5066413A (en) * 1989-04-04 1991-11-19 Creative Products Resource Associates, Ltd. Gelled, dryer-added fabric-modifier sheet
US5208031A (en) * 1989-06-06 1993-05-04 Kelly Patrick D Sexual lubricants containing zinc as an anti-viral agent
US5482053A (en) * 1989-06-06 1996-01-09 Kelly; Patrick D. Condom lubricants containing zinc as an anti-viral agent
US5624675A (en) * 1989-06-06 1997-04-29 Kelly; Patrick D. Genital lubricants containing zinc salts to reduce risk of HIV infection
US5599551A (en) * 1989-06-06 1997-02-04 Kelly; Patrick D. Genital lubricants containing zinc as an anti-viral agent
US5785054A (en) * 1989-06-06 1998-07-28 Kelly; Patrick D. Genital lubricant with zinc salt, labelled as anti-viral agent
DE3930725A1 (en) * 1989-09-14 1991-03-21 Benckiser Gmbh Joh A EXTRA-MILDE SHOWER AND HAIR SHAMPOO FORMULATION WITH LOW TENSION CONCENTRATION
US5980477A (en) * 1991-07-29 1999-11-09 Patrick Kelly Genital lubricants with zinc salts as anti-viral additives
EP0678030A1 (en) 1993-01-08 1995-10-25 The Population Council Use of sulphated polysaccharides for preventing sexually transmitted diseases
US6321750B1 (en) * 1993-05-03 2001-11-27 Patrick D. Kelly Condom lubricants with zinc salts as anti-viral additives
JP2717497B2 (en) 1993-12-28 1998-02-18 不二ラテックス株式会社 Acid polysaccharide coated condoms
US5658893A (en) * 1995-03-29 1997-08-19 Abbott Laboratories Method for inhibition of rotavirus infection with carrageenan
US5667773A (en) * 1996-03-12 1997-09-16 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
GB9704022D0 (en) 1997-02-26 1997-04-16 York Rehabilitation Limited Protective barrier composition
IT1297461B1 (en) 1997-10-29 1999-12-17 Ciocca Maurizio PREPARATION OF CONTROLLED RELEASE TABLETS BASED ON COMPLEXES BETWEEN CARRAGENANO AND SOLUBLE BASIC DRUGS
GB9803770D0 (en) * 1998-02-23 1998-04-15 Unilever Plc Detergent compositions
PL204211B1 (en) 1998-05-18 2009-12-31 Rockwool Int Stabilized aqueous phenolic binder for mineral wool and production of mineral wool products
EP0958832B1 (en) * 1998-05-21 2006-01-25 Nipro Corporation Albumin containing peritoneal dialysis fluid
WO2000038653A1 (en) 1998-12-23 2000-07-06 Idea Ag. Improved formulation for topical non-invasive application in vivo
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
US6248339B1 (en) * 1999-08-13 2001-06-19 Intimate Beauty Corporation Fragrant body lotion and cream
JP5241978B2 (en) 1999-10-13 2013-07-17 帝國製薬株式会社 Kampo jelly pharmaceutical composition
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
FR2807058B1 (en) 2000-03-30 2002-06-14 Condat Sa EMERGENCY MASTIC FOR THE PREVENTION AND THE COMING OF WATER, FOR TUNNEL TAILS
US6248360B1 (en) * 2000-06-21 2001-06-19 International Health Management Associates, Inc. Complexes to improve oral absorption of poorly absorbable antibiotics
US7223417B2 (en) * 2000-10-27 2007-05-29 Calton Gary J Nutrient formulations
US6696071B2 (en) * 2001-11-27 2004-02-24 Patrick D. Kelly Pre-coital and post-coital rinse with anti-viral and skin-protective zinc salts
AU2003245252A1 (en) * 2002-04-30 2003-11-17 Fmc Corporation Carrageenan based antimicrobial compositions
CA2384474A1 (en) 2002-04-30 2003-10-30 The Population Council, Inc. Compositions and methods for protecting against sexually transmitted diseases
US20040071679A1 (en) * 2002-10-15 2004-04-15 Claudio De Simone Identifying and treating vaginal infections
US20060147504A1 (en) * 2004-12-30 2006-07-06 Bobby Corry Feminine anti-itch cloth
JP5217136B2 (en) * 2005-10-18 2013-06-19 大正製薬株式会社 Semi-solid formulation for rectal, urethral and vaginal applications.

Also Published As

Publication number Publication date
BR112012008040B1 (en) 2019-12-24
MX2012004008A (en) 2012-09-07
EP2485710A1 (en) 2012-08-15
US20100256089A1 (en) 2010-10-07
ES2550815T3 (en) 2015-11-12
CN102665677B (en) 2014-06-18
RU2540423C2 (en) 2015-02-10
CO6531457A2 (en) 2012-09-28
WO2011044034A1 (en) 2011-04-14
US8367098B2 (en) 2013-02-05
EP2485710B1 (en) 2015-07-22
CN102665677A (en) 2012-09-12
CA2775603C (en) 2015-12-15
JP5911425B2 (en) 2016-04-27
AU2010303721A1 (en) 2012-05-24
RU2012118600A (en) 2013-11-20
MX337376B (en) 2016-02-29
ZA201202526B (en) 2013-05-29
AU2010303721B2 (en) 2014-05-01
CA2775603A1 (en) 2011-04-14
BR112012008040A2 (en) 2016-03-01
JP2013506712A (en) 2013-02-28
UA109117C2 (en) 2015-07-27

Similar Documents

Publication Publication Date Title
IN2012DN02879A (en)
NO20092609L (en) Tannate salt or rasagiline
MY162655A (en) Metal salt compositions
BRPI1013761A2 (en) use of s- (3-aminopropyl) thiosulfuric acid or metal salt thereof.
BRPI0816979A2 (en) Effective method of block data transmission using header indicator.
WO2007117433A3 (en) Antimicrobial compositions comprising hop acid alkali salts and uses thereof
GB0712287D0 (en) Antimicrobial Conjugates
ES2531093T3 (en) Preparation procedure for N-alkyl-naltrexone halides
WO2007101700A3 (en) Method for providing certain information
GB2471610A (en) Cooperative communications techniques
PH12013502448A1 (en) Processes and intermediates for making sweet taste enhancers
GB2491077A (en) System and method for strategic routing in a peer-to-peer environment
UA104897C2 (en) Method for increasing the seedling growth and/or the early emergence of crops
FR2934865B1 (en) SEMI-AROMATIC COPOLYAMIDE AND PROCESS FOR PREPARING THE SAME
WO2011005594A3 (en) Antimicrobial compositions and methods of making and using the same
BRPI0519316B8 (en) aqueous herbicidal composition; and, process for preparing a composition.
MD20080220A3 (en) Herbicidal composition
PH12013502194A1 (en) Antibodies to egfl7 and methods for their use
FR2956541B1 (en) CRYPTOGRAPHIC METHOD FOR COMMUNICATING CONFIDENTIAL INFORMATION.
WO2011160078A3 (en) Use of camelid-derived variable heavy chain variable regions targeting cd18 and icam-1 as a microbicide to prevent hiv-1 transmission
MX2009009490A (en) Novel prodrugs.
FR2975851B1 (en) METHOD OF TRANSMITTING THE UPLINK OF AN AIRCRAFT.
MX376013B (en) ZINC PHOSPHATE COMPLEX.
BR112014010919A2 (en) polymer composition and method for preparing (co) methacrylic anhydride hypophosphite telomeres
FI20075765A7 (en) Cheese and method for making it